Related Experiment Video
Updated: Dec 15, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine Development.
Linh Chi Nguyen1, Christopher W Bakerlee2,3, T Greg McKelvey4
1Department of Politics and International Relations, University of Oxford, Oxford, United Kingdom.
Human challenge trials (HCTs) can accelerate SARS-CoV-2 vaccine development by evaluating efficacy and improving immune response understanding. Preserving the option for HCTs is crucial, with immediate planning recommended.
Area of Science:
- Infectious Diseases
- Vaccinology
- Immunology
Background:
- Human challenge trials (HCTs) offer a potential method to expedite the development of vaccines against SARS-CoV-2.
- The COVID-19 pandemic necessitates exploring innovative approaches for rapid vaccine advancement.
Purpose of the Study:
- To identify and discuss key use cases for HCTs in SARS-CoV-2 vaccine development.
- To evaluate the limitations and benefits of employing HCTs for pandemic response.
- To recommend immediate actions for establishing HCT readiness.
Main Methods:
- Review and analysis of potential applications of HCTs in the context of SARS-CoV-2.
- Discussion of the utility of HCTs for preclinical vaccine candidates.
- Identification of necessary preparatory steps for conducting HCTs.
Main Results:
- HCTs can be valuable for evaluating vaccine efficacy, identifying correlates of protection, and understanding pathogenesis and immune responses.
- HCTs are most beneficial for vaccine candidates in early preclinical development stages.
- Despite limitations, specific scenarios exist where HCTs offer significant advantages.
Conclusions:
- The option to conduct HCTs for SARS-CoV-2 vaccine development should be maintained.
- Immediate establishment of guidelines, preparation of challenge agents, and logistical arrangements are recommended.
- Periodic re-evaluation of HCT utility is advised to adapt to evolving pandemic dynamics.
More Related Videos
Related Concept Videos
Preclinical Development: Overview
Clinical Trials: Overview
Bioequivalence studies: Biowaivers
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...

